The detection of IgM antibodies, specific to the measles virus, with the use of commercial, 96-well plate-based enzyme-linked immunosorbent assays (ELISA or EIA) is broadly used within the WHO global measles and rubella laboratory network (10). The gene discussed is CD40LG; the disease is rubella.